var eventsData = [{"Ticker":"CVS","EffectiveDate":"2017-02-02","Type":"RatingNeutral","Title":"Baird downgrades CVS to Neutral from Outperform.","DailyReturn":-0.040657,"FiveDayReturnAfter":-0.012131,"FiveDayReturnBefore":-0.019308},{"Ticker":"CVS","EffectiveDate":"2017-01-20","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":-0.013785,"FiveDayReturnAfter":-0.041604,"FiveDayReturnBefore":0.005182},{"Ticker":"CVS","EffectiveDate":"2016-12-12","Type":"RatingNeutral","Title":"Jefferies assumes CVS to Hold from Buy. Target Price is $82; previously $122.","DailyReturn":-0.004992,"FiveDayReturnAfter":-0.007138,"FiveDayReturnBefore":0.031825},{"Ticker":"CVS","EffectiveDate":"2016-11-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.11824,"FiveDayReturnAfter":-0.092795,"FiveDayReturnBefore":-0.008478},{"Ticker":"CVS","EffectiveDate":"2016-11-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.11824,"FiveDayReturnAfter":-0.092795,"FiveDayReturnBefore":-0.008478},{"Ticker":"CVS","EffectiveDate":"2016-11-08","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CVS reports 2016 Q3's earning $1.64 per share and revenue $44615MM. This beats analyst's estimated EPS $1.57, misses estimated revenue $45290MM.","DailyReturn":-0.11824,"FiveDayReturnAfter":-0.092795,"FiveDayReturnBefore":-0.008478},{"Ticker":"CVS","EffectiveDate":"2016-11-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.11824,"FiveDayReturnAfter":-0.092795,"FiveDayReturnBefore":-0.008478},{"Ticker":"CVS","EffectiveDate":"2016-11-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.11824,"FiveDayReturnAfter":-0.092795,"FiveDayReturnBefore":-0.008478},{"Ticker":"CVS","EffectiveDate":"2016-10-20","Type":"Dividend","Title":"The Firm pays dividend $0.425","DailyReturn":0.015411,"FiveDayReturnAfter":0.018379,"FiveDayReturnBefore":-0.012308},{"Ticker":"CVS","EffectiveDate":"2016-10-06","Type":"RatingNeutral","Title":"UBS initiates coverage on CVS to Buy.","DailyReturn":0.003364,"FiveDayReturnAfter":0.014625,"FiveDayReturnBefore":-0.045139},{"Ticker":"CVS","EffectiveDate":"2016-10-03","Type":"RatingNeutral","Title":"Bank of America maintains CVS to Buy. Target Price is $107; previously $110.","DailyReturn":-0.021351,"FiveDayReturnAfter":-0.029538,"FiveDayReturnBefore":-0.017932},{"Ticker":"CVS","EffectiveDate":"2016-10-03","Type":"RatingNeutral","Title":"Baird maintains CVS to Outperform. Target Price is $104; previously $114.","DailyReturn":-0.021351,"FiveDayReturnAfter":-0.029538,"FiveDayReturnBefore":-0.017932},{"Ticker":"CVS","EffectiveDate":"2016-08-08","Type":"RatingNeutral","Title":"Citigroup maintains CVS to Neutral. Target Price is $108; previously $115.","DailyReturn":-0.001951,"FiveDayReturnAfter":0.000615,"FiveDayReturnBefore":0.048935},{"Ticker":"CVS","EffectiveDate":"2016-08-03","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVS to Hold. Target Price is $108; previously $99.","DailyReturn":-0.006425,"FiveDayReturnAfter":-0.00624,"FiveDayReturnBefore":0.043882},{"Ticker":"CVS","EffectiveDate":"2016-08-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.048882,"FiveDayReturnAfter":0.038711,"FiveDayReturnBefore":-0.005865},{"Ticker":"CVS","EffectiveDate":"2016-08-02","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CVS reports 2016 Q2's earning $1.32 per share and revenue $43725MM. This beats analyst's estimated EPS $1.3, misses estimated revenue $44280MM.","DailyReturn":0.048882,"FiveDayReturnAfter":0.038711,"FiveDayReturnBefore":-0.005865},{"Ticker":"CVS","EffectiveDate":"2016-08-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.048882,"FiveDayReturnAfter":0.038711,"FiveDayReturnBefore":-0.005865},{"Ticker":"CVS","EffectiveDate":"2016-07-19","Type":"Dividend","Title":"The Firm pays dividend $0.425","DailyReturn":0.004718,"FiveDayReturnAfter":-0.025253,"FiveDayReturnBefore":0.000309},{"Ticker":"CVS","EffectiveDate":"2016-06-20","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CVS to Equal-Weight. Target Price is $104; previously $111.","DailyReturn":-0.016976,"FiveDayReturnAfter":-0.013803,"FiveDayReturnBefore":-0.019112},{"Ticker":"CVS","EffectiveDate":"2016-06-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.006369,"FiveDayReturnAfter":-0.026984,"FiveDayReturnBefore":-0.005518},{"Ticker":"CVS","EffectiveDate":"2016-06-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.006369,"FiveDayReturnAfter":-0.026984,"FiveDayReturnBefore":-0.005518},{"Ticker":"CVS","EffectiveDate":"2016-06-02","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.001864,"FiveDayReturnAfter":0.017754,"FiveDayReturnBefore":-0.00825},{"Ticker":"CVS","EffectiveDate":"2016-05-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.005055,"FiveDayReturnAfter":-0.006521,"FiveDayReturnBefore":-0.025664},{"Ticker":"CVS","EffectiveDate":"2016-05-31","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.005055,"FiveDayReturnAfter":-0.006521,"FiveDayReturnBefore":-0.025664},{"Ticker":"CVS","EffectiveDate":"2016-05-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.001746,"FiveDayReturnAfter":-0.00825,"FiveDayReturnBefore":-0.047431},{"Ticker":"CVS","EffectiveDate":"2016-05-25","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.001746,"FiveDayReturnAfter":-0.00825,"FiveDayReturnBefore":-0.047431},{"Ticker":"CVS","EffectiveDate":"2016-05-20","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.01476,"FiveDayReturnAfter":-0.040431,"FiveDayReturnBefore":-0.037906},{"Ticker":"CVS","EffectiveDate":"2016-05-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.008489,"FiveDayReturnAfter":-0.041458,"FiveDayReturnBefore":-0.011319},{"Ticker":"CVS","EffectiveDate":"2016-05-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.008489,"FiveDayReturnAfter":-0.041458,"FiveDayReturnBefore":-0.011319},{"Ticker":"CVS","EffectiveDate":"2016-05-16","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.008489,"FiveDayReturnAfter":-0.041458,"FiveDayReturnBefore":-0.011319},{"Ticker":"CVS","EffectiveDate":"2016-05-16","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.008489,"FiveDayReturnAfter":-0.041458,"FiveDayReturnBefore":-0.011319},{"Ticker":"CVS","EffectiveDate":"2016-05-12","Type":"RatingNeutral","Title":"Jefferies maintains CVS to Buy. Target Price is $122; previously $110.","DailyReturn":0.006624,"FiveDayReturnAfter":-0.025673,"FiveDayReturnBefore":0.002499},{"Ticker":"CVS","EffectiveDate":"2016-05-09","Type":"RatingNeutral","Title":"Citigroup maintains CVS to Neutral. Target Price is $115; previously $105.","DailyReturn":0.008488,"FiveDayReturnAfter":-0.011319,"FiveDayReturnBefore":0.042374},{"Ticker":"CVS","EffectiveDate":"2016-05-03","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.024347,"FiveDayReturnAfter":0.041417,"FiveDayReturnBefore":-0.004915},{"Ticker":"CVS","EffectiveDate":"2016-05-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.024347,"FiveDayReturnAfter":0.041417,"FiveDayReturnBefore":-0.004915},{"Ticker":"CVS","EffectiveDate":"2016-05-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.024347,"FiveDayReturnAfter":0.041417,"FiveDayReturnBefore":-0.004915},{"Ticker":"CVS","EffectiveDate":"2016-05-03","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.024347,"FiveDayReturnAfter":0.041417,"FiveDayReturnBefore":-0.004915},{"Ticker":"CVS","EffectiveDate":"2016-04-20","Type":"Dividend","Title":"The Firm pays dividend $0.425","DailyReturn":-0.005095,"FiveDayReturnAfter":-0.001797,"FiveDayReturnBefore":0.02179},{"Ticker":"CVS","EffectiveDate":"2016-03-15","Type":"RatingNeutral","Title":"Credit Suisse assumes CVS to Outperform. Target Price is $115.","DailyReturn":0.001584,"FiveDayReturnAfter":0.007101,"FiveDayReturnBefore":0.026074},{"Ticker":"CVS","EffectiveDate":"2016-03-10","Type":"RatingNeutral","Title":"Barclays assumes CVS to Overweight. Target Price is $115; previously $110.","DailyReturn":-0.011739,"FiveDayReturnAfter":0.004566,"FiveDayReturnBefore":0.01898},{"Ticker":"CVS","EffectiveDate":"2016-02-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.009593,"FiveDayReturnAfter":0.078178,"FiveDayReturnBefore":-0.08209},{"Ticker":"CVS","EffectiveDate":"2016-02-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.009593,"FiveDayReturnAfter":0.078178,"FiveDayReturnBefore":-0.08209},{"Ticker":"CVS","EffectiveDate":"2016-02-03","Type":"RatingNeutral","Title":"Atlantic Equities initiates coverage on CVS to Overweight.","DailyReturn":0.004529,"FiveDayReturnAfter":-0.047784,"FiveDayReturnBefore":0.009526},{"Ticker":"CVS","EffectiveDate":"2016-01-22","Type":"RatingNeutral","Title":"Baird initiates coverage on CVS to Outperform. Target Price is $108.","DailyReturn":0.012278,"FiveDayReturnAfter":-0.010534,"FiveDayReturnBefore":0.008404},{"Ticker":"CVS","EffectiveDate":"2016-01-21","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.003825,"FiveDayReturnAfter":0.002335,"FiveDayReturnBefore":-0.012064},{"Ticker":"CVS","EffectiveDate":"2016-01-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003825,"FiveDayReturnAfter":0.002335,"FiveDayReturnBefore":-0.012064},{"Ticker":"CVS","EffectiveDate":"2016-01-20","Type":"Dividend","Title":"The Firm pays dividend $0.425","DailyReturn":-0.005442,"FiveDayReturnAfter":-0.006307,"FiveDayReturnBefore":0.001472},{"Ticker":"CVS","EffectiveDate":"2015-12-18","Type":"RatingNeutral","Title":"Barclays assumes CVS to Overweight. Target Price is $110.","DailyReturn":0.001584,"FiveDayReturnAfter":0.042885,"FiveDayReturnBefore":-0.000316},{"Ticker":"CVS","EffectiveDate":"2015-12-17","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CVS to Neutral from Buy.","DailyReturn":-0.029213,"FiveDayReturnAfter":0.00969,"FiveDayReturnBefore":0.026802},{"Ticker":"CVS","EffectiveDate":"2015-12-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.053678,"FiveDayReturnAfter":0.059538,"FiveDayReturnBefore":-0.032619},{"Ticker":"CVS","EffectiveDate":"2015-12-16","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.053678,"FiveDayReturnAfter":0.059538,"FiveDayReturnBefore":-0.032619},{"Ticker":"CVS","EffectiveDate":"2015-11-02","Type":"RatingNeutral","Title":"JP Morgan maintains CVS to Overweight. Target Price is $123; previously $128.","DailyReturn":0.016198,"FiveDayReturnAfter":-0.00081,"FiveDayReturnBefore":-0.051015},{"Ticker":"CVS","EffectiveDate":"2015-11-02","Type":"RatingNeutral","Title":"Oppenheimer maintains CVS to Outperform. Target Price is $115; previously $122.","DailyReturn":0.016198,"FiveDayReturnAfter":-0.00081,"FiveDayReturnBefore":-0.051015},{"Ticker":"CVS","EffectiveDate":"2015-10-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.048362,"FiveDayReturnAfter":-0.041906,"FiveDayReturnBefore":-0.004709},{"Ticker":"CVS","EffectiveDate":"2015-10-30","Type":"EarningsRelease","Title":"Before market open, CVS reports 2015 Q3's earning $1.29 per share and revenue $38644MM. This meets analyst's estimated EPS $1.29, beats estimated revenue $37890MM.","DailyReturn":-0.048362,"FiveDayReturnAfter":-0.041906,"FiveDayReturnBefore":-0.004709},{"Ticker":"CVS","EffectiveDate":"2015-10-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.048362,"FiveDayReturnAfter":-0.041906,"FiveDayReturnBefore":-0.004709},{"Ticker":"CVS","EffectiveDate":"2015-10-20","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":0.004265,"FiveDayReturnAfter":0.003,"FiveDayReturnBefore":0.00426},{"Ticker":"CVS","EffectiveDate":"2015-10-06","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.021085,"FiveDayReturnAfter":0.01073,"FiveDayReturnBefore":0.056692},{"Ticker":"CVS","EffectiveDate":"2015-10-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.021085,"FiveDayReturnAfter":0.01073,"FiveDayReturnBefore":0.056692},{"Ticker":"CVS","EffectiveDate":"2015-09-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.008721,"FiveDayReturnAfter":-0.046243,"FiveDayReturnBefore":0.007459},{"Ticker":"CVS","EffectiveDate":"2015-09-22","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.008721,"FiveDayReturnAfter":-0.046243,"FiveDayReturnBefore":0.007459},{"Ticker":"CVS","EffectiveDate":"2015-08-28","Type":"RatingNeutral","Title":"Oppenheimer maintains CVS to Outperform. Target Price is $122; previously $119.","DailyReturn":-0.009696,"FiveDayReturnAfter":-0.034919,"FiveDayReturnBefore":-0.007766},{"Ticker":"CVS","EffectiveDate":"2015-08-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.002575,"FiveDayReturnAfter":-0.081692,"FiveDayReturnBefore":0.001106},{"Ticker":"CVS","EffectiveDate":"2015-08-18","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":-0.002575,"FiveDayReturnAfter":-0.081692,"FiveDayReturnBefore":0.001106},{"Ticker":"CVS","EffectiveDate":"2015-08-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.02535,"FiveDayReturnAfter":-0.037938,"FiveDayReturnBefore":0.027407},{"Ticker":"CVS","EffectiveDate":"2015-08-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.02535,"FiveDayReturnAfter":-0.037938,"FiveDayReturnBefore":0.027407},{"Ticker":"CVS","EffectiveDate":"2015-07-21","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":-0.005152,"FiveDayReturnAfter":-0.007802,"FiveDayReturnBefore":0.016534},{"Ticker":"CVS","EffectiveDate":"2015-07-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.007627,"FiveDayReturnAfter":0.006333,"FiveDayReturnBefore":0.024818},{"Ticker":"CVS","EffectiveDate":"2015-07-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.007627,"FiveDayReturnAfter":0.006333,"FiveDayReturnBefore":0.024818},{"Ticker":"CVS","EffectiveDate":"2015-07-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016009,"FiveDayReturnAfter":0.024818,"FiveDayReturnBefore":0.017747},{"Ticker":"CVS","EffectiveDate":"2015-07-13","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.016009,"FiveDayReturnAfter":0.024818,"FiveDayReturnBefore":0.017747},{"Ticker":"CVS","EffectiveDate":"2015-06-18","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on CVS to Outperform. Target Price is $119.","DailyReturn":0.011944,"FiveDayReturnAfter":0.01444,"FiveDayReturnBefore":0.016413},{"Ticker":"CVS","EffectiveDate":"2015-06-12","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.003995,"FiveDayReturnAfter":0.023402,"FiveDayReturnBefore":0.017297},{"Ticker":"CVS","EffectiveDate":"2015-06-10","Type":"RatingNeutral","Title":"Cowen & Co. maintains CVS to Outperform. Target Price is $115; previously $108.","DailyReturn":0.021504,"FiveDayReturnAfter":0.031409,"FiveDayReturnBefore":-0.018334},{"Ticker":"CVS","EffectiveDate":"2015-06-09","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CVS to Outperform. Target Price is $115.","DailyReturn":0.005734,"FiveDayReturnAfter":0.031391,"FiveDayReturnBefore":-0.030708},{"Ticker":"CVS","EffectiveDate":"2015-05-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010262,"FiveDayReturnAfter":0.011273,"FiveDayReturnBefore":0.020537},{"Ticker":"CVS","EffectiveDate":"2015-05-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010262,"FiveDayReturnAfter":0.011273,"FiveDayReturnBefore":0.020537},{"Ticker":"CVS","EffectiveDate":"2015-05-20","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.010262,"FiveDayReturnAfter":0.011273,"FiveDayReturnBefore":0.020537},{"Ticker":"CVS","EffectiveDate":"2015-05-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.010262,"FiveDayReturnAfter":0.011273,"FiveDayReturnBefore":0.020537},{"Ticker":"CVS","EffectiveDate":"2015-05-20","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.010262,"FiveDayReturnAfter":0.011273,"FiveDayReturnBefore":0.020537},{"Ticker":"CVS","EffectiveDate":"2015-05-12","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.002488,"FiveDayReturnAfter":0.019218,"FiveDayReturnBefore":0.003291},{"Ticker":"CVS","EffectiveDate":"2015-05-07","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.004956,"FiveDayReturnAfter":0.009463,"FiveDayReturnBefore":-0.01804},{"Ticker":"CVS","EffectiveDate":"2015-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.011784,"FiveDayReturnAfter":0.000707,"FiveDayReturnBefore":-0.015886},{"Ticker":"CVS","EffectiveDate":"2015-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.011784,"FiveDayReturnAfter":0.000707,"FiveDayReturnBefore":-0.015886},{"Ticker":"CVS","EffectiveDate":"2015-04-27","Type":"RatingNeutral","Title":"Jefferies maintains CVS to Buy. Target Price is $120; previously $115.","DailyReturn":-0.003544,"FiveDayReturnAfter":-0.011086,"FiveDayReturnBefore":0.015241},{"Ticker":"CVS","EffectiveDate":"2015-04-22","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":0.001682,"FiveDayReturnAfter":0.008965,"FiveDayReturnBefore":-0.006879},{"Ticker":"CVS","EffectiveDate":"2015-03-05","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.002716,"FiveDayReturnAfter":-0.014856,"FiveDayReturnBefore":-0.003486},{"Ticker":"CVS","EffectiveDate":"2015-02-13","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVS to Hold. Target Price is $109; previously $100.","DailyReturn":-0.003592,"FiveDayReturnAfter":-0.002916,"FiveDayReturnBefore":0.021988},{"Ticker":"CVS","EffectiveDate":"2015-02-13","Type":"RatingNeutral","Title":"Citigroup maintains CVS to Neutral. Target Price is $110; previously $102.","DailyReturn":-0.003592,"FiveDayReturnAfter":-0.002916,"FiveDayReturnBefore":0.021988},{"Ticker":"CVS","EffectiveDate":"2015-02-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.021294,"FiveDayReturnAfter":0.039295,"FiveDayReturnBefore":0.004531},{"Ticker":"CVS","EffectiveDate":"2015-02-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.021294,"FiveDayReturnAfter":0.039295,"FiveDayReturnBefore":0.004531},{"Ticker":"CVS","EffectiveDate":"2015-01-21","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CVS to Buy from Neutral. Target Price is $113; previously $95.","DailyReturn":0.011487,"FiveDayReturnAfter":0.024601,"FiveDayReturnBefore":0.015518},{"Ticker":"CVS","EffectiveDate":"2015-01-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000203,"FiveDayReturnAfter":0.026281,"FiveDayReturnBefore":0.008341},{"Ticker":"CVS","EffectiveDate":"2015-01-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.000203,"FiveDayReturnAfter":0.026281,"FiveDayReturnBefore":0.008341},{"Ticker":"CVS","EffectiveDate":"2015-01-20","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":-0.000203,"FiveDayReturnAfter":0.026281,"FiveDayReturnBefore":0.008341},{"Ticker":"CVS","EffectiveDate":"2015-01-08","Type":"RatingNeutral","Title":"JP Morgan maintains CVS to Overweight. Target Price is $116; previously $108.","DailyReturn":0.021266,"FiveDayReturnAfter":0.014491,"FiveDayReturnBefore":-0.016542},{"Ticker":"CVS","EffectiveDate":"2015-01-02","Type":"RatingNeutral","Title":"Bank of America maintains CVS to Buy. Target Price is $104; previously $94.","DailyReturn":-0.012564,"FiveDayReturnAfter":0.017089,"FiveDayReturnBefore":-0.016069},{"Ticker":"CVS","EffectiveDate":"2014-12-19","Type":"RatingUpgrade","Title":"SunTrust Robinson Humphrey upgrades CVS to Buy. Target Price is $110.","DailyReturn":0.001884,"FiveDayReturnAfter":0.02818,"FiveDayReturnBefore":0.049247},{"Ticker":"CVS","EffectiveDate":"2014-12-17","Type":"RatingNeutral","Title":"Credit Suisse maintains CVS to Outperform. Target Price is $101; previously $95.","DailyReturn":0.02015,"FiveDayReturnAfter":0.058489,"FiveDayReturnBefore":0.01155},{"Ticker":"CVS","EffectiveDate":"2014-12-17","Type":"RatingNeutral","Title":"JP Morgan maintains CVS to Overweight. Target Price is $108; previously $92.","DailyReturn":0.02015,"FiveDayReturnAfter":0.058489,"FiveDayReturnBefore":0.01155},{"Ticker":"CVS","EffectiveDate":"2014-12-17","Type":"RatingNeutral","Title":"Barclays maintains CVS to Overweight. Target Price is $107; previously $98.","DailyReturn":0.02015,"FiveDayReturnAfter":0.058489,"FiveDayReturnBefore":0.01155},{"Ticker":"CVS","EffectiveDate":"2014-12-16","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.02715,"FiveDayReturnAfter":0.077481,"FiveDayReturnBefore":-0.009854},{"Ticker":"CVS","EffectiveDate":"2014-12-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.02715,"FiveDayReturnAfter":0.077481,"FiveDayReturnBefore":-0.009854},{"Ticker":"CVS","EffectiveDate":"2014-12-10","Type":"RatingNeutral","Title":"Citigroup initiates coverage on CVS to Neutral. Target Price is $99.","DailyReturn":-0.012493,"FiveDayReturnAfter":0.01155,"FiveDayReturnBefore":0.012794},{"Ticker":"CVS","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"FBR Capital maintains CVS to Outperform. Target Price is $92; previously $90.","DailyReturn":0.023751,"FiveDayReturnAfter":0.048975,"FiveDayReturnBefore":0.003163},{"Ticker":"CVS","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVS to Hold. Target Price is $90; previously $84.","DailyReturn":0.023751,"FiveDayReturnAfter":0.048975,"FiveDayReturnBefore":0.003163},{"Ticker":"CVS","EffectiveDate":"2014-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.007548,"FiveDayReturnAfter":0.035027,"FiveDayReturnBefore":0.014974},{"Ticker":"CVS","EffectiveDate":"2014-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.007548,"FiveDayReturnAfter":0.035027,"FiveDayReturnBefore":0.014974},{"Ticker":"CVS","EffectiveDate":"2014-10-21","Type":"Dividend","Title":"The Firm pays dividend $0.275","DailyReturn":0.017611,"FiveDayReturnAfter":0.040349,"FiveDayReturnBefore":0.020261},{"Ticker":"CVS","EffectiveDate":"2014-09-15","Type":"RatingUpgrade","Title":"Cowen & Co. upgrades CVS to Outperform from Market Perform. Target Price is $92; previously $85.","DailyReturn":0.008316,"FiveDayReturnAfter":0.009881,"FiveDayReturnBefore":-0.013193},{"Ticker":"CVS","EffectiveDate":"2014-09-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016561,"FiveDayReturnAfter":0.009666,"FiveDayReturnBefore":0.011019},{"Ticker":"CVS","EffectiveDate":"2014-09-05","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.016561,"FiveDayReturnAfter":0.009666,"FiveDayReturnBefore":0.011019},{"Ticker":"CVS","EffectiveDate":"2014-09-03","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.007902,"FiveDayReturnAfter":0.014074,"FiveDayReturnBefore":0.006542},{"Ticker":"CVS","EffectiveDate":"2014-09-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.007902,"FiveDayReturnAfter":0.014074,"FiveDayReturnBefore":0.006542},{"Ticker":"CVS","EffectiveDate":"2014-08-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.007914,"FiveDayReturnAfter":-0.002265,"FiveDayReturnBefore":0.008831},{"Ticker":"CVS","EffectiveDate":"2014-08-21","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.007914,"FiveDayReturnAfter":-0.002265,"FiveDayReturnBefore":0.008831},{"Ticker":"CVS","EffectiveDate":"2014-08-07","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.011943,"FiveDayReturnAfter":0.024113,"FiveDayReturnBefore":-0.009175},{"Ticker":"CVS","EffectiveDate":"2014-08-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011943,"FiveDayReturnAfter":0.024113,"FiveDayReturnBefore":-0.009175},{"Ticker":"CVS","EffectiveDate":"2014-08-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011943,"FiveDayReturnAfter":0.024113,"FiveDayReturnBefore":-0.009175},{"Ticker":"CVS","EffectiveDate":"2014-08-07","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.011943,"FiveDayReturnAfter":0.024113,"FiveDayReturnBefore":-0.009175},{"Ticker":"CVS","EffectiveDate":"2014-08-06","Type":"RatingNeutral","Title":"JP Morgan maintains CVS to Overweight. Target Price is $91; previously $82.","DailyReturn":-0.003106,"FiveDayReturnAfter":0.017956,"FiveDayReturnBefore":-0.006964},{"Ticker":"CVS","EffectiveDate":"2014-08-06","Type":"RatingNeutral","Title":"Barclays maintains CVS to Overweight. Target Price is $87; previously $85.","DailyReturn":-0.003106,"FiveDayReturnAfter":0.017956,"FiveDayReturnBefore":-0.006964},{"Ticker":"CVS","EffectiveDate":"2014-08-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.001293,"FiveDayReturnAfter":0.012714,"FiveDayReturnBefore":-0.012969},{"Ticker":"CVS","EffectiveDate":"2014-08-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.001293,"FiveDayReturnAfter":0.012714,"FiveDayReturnBefore":-0.012969},{"Ticker":"CVS","EffectiveDate":"2014-07-17","Type":"Dividend","Title":"The Firm pays dividend $0.275","DailyReturn":-0.008403,"FiveDayReturnAfter":0.017755,"FiveDayReturnBefore":0.002471},{"Ticker":"CVS","EffectiveDate":"2014-05-08","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.000527,"FiveDayReturnAfter":0.001316,"FiveDayReturnBefore":0.0428},{"Ticker":"CVS","EffectiveDate":"2014-05-05","Type":"RatingNeutral","Title":"Barclays maintains CVS to Overweight. Target Price is $85; previously $74.","DailyReturn":0.015164,"FiveDayReturnAfter":0.032239,"FiveDayReturnBefore":0.00843},{"Ticker":"CVS","EffectiveDate":"2014-05-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.010535,"FiveDayReturnAfter":0.037198,"FiveDayReturnBefore":0.000273},{"Ticker":"CVS","EffectiveDate":"2014-05-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010535,"FiveDayReturnAfter":0.037198,"FiveDayReturnBefore":0.000273},{"Ticker":"CVS","EffectiveDate":"2014-04-17","Type":"Dividend","Title":"The Firm pays dividend $0.275","DailyReturn":0.001426,"FiveDayReturnAfter":-0.007702,"FiveDayReturnBefore":-0.007278},{"Ticker":"CVS","EffectiveDate":"2014-02-11","Type":"EarningsRevenueBeat","Title":"Before market open, CVS reports 2013 Q4's earning $1.12 per share and revenue $32800MM. This beats analyst's estimated EPS $1.11, beats estimated revenue $32670MM.","DailyReturn":0.027338,"FiveDayReturnAfter":0.049261,"FiveDayReturnBefore":0.017329},{"Ticker":"CVS","EffectiveDate":"2014-02-11","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.027338,"FiveDayReturnAfter":0.049261,"FiveDayReturnBefore":0.017329},{"Ticker":"CVS","EffectiveDate":"2014-02-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.027338,"FiveDayReturnAfter":0.049261,"FiveDayReturnBefore":0.017329},{"Ticker":"CVS","EffectiveDate":"2014-02-05","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.010135,"FiveDayReturnAfter":0.039448,"FiveDayReturnBefore":-0.035806},{"Ticker":"CVS","EffectiveDate":"2014-01-22","Type":"RatingUpgrade","Title":"ISI Group upgrades CVS to Strong Buy from Buy. Target Price is $78.5.","DailyReturn":0.012441,"FiveDayReturnAfter":0.002922,"FiveDayReturnBefore":0.000695},{"Ticker":"CVS","EffectiveDate":"2014-01-21","Type":"Dividend","Title":"The Firm pays dividend $0.275","DailyReturn":0.009233,"FiveDayReturnAfter":-0.002441,"FiveDayReturnBefore":-0.022403},{"Ticker":"CVS","EffectiveDate":"2014-01-09","Type":"RatingNeutral","Title":"Leerink Swann initiates coverage on CVS to Outperform. Target Price is $85.","DailyReturn":0.00215,"FiveDayReturnAfter":-0.021439,"FiveDayReturnBefore":-0.025471},{"Ticker":"CVS","EffectiveDate":"2014-01-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00215,"FiveDayReturnAfter":-0.021439,"FiveDayReturnBefore":-0.025471},{"Ticker":"CVS","EffectiveDate":"2014-01-09","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.00215,"FiveDayReturnAfter":-0.021439,"FiveDayReturnBefore":-0.025471},{"Ticker":"CVS","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVS to Hold. Target Price is $76; previously $71.","DailyReturn":-0.001141,"FiveDayReturnAfter":0.020042,"FiveDayReturnBefore":0.037329},{"Ticker":"CVS","EffectiveDate":"2013-12-19","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVS to Overweight. Target Price is $76; previously $65.","DailyReturn":0.006457,"FiveDayReturnAfter":0.022558,"FiveDayReturnBefore":0.022493},{"Ticker":"CVS","EffectiveDate":"2013-12-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.043107,"FiveDayReturnAfter":0.060545,"FiveDayReturnBefore":-0.017507},{"Ticker":"CVS","EffectiveDate":"2013-12-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.043107,"FiveDayReturnAfter":0.060545,"FiveDayReturnBefore":-0.017507},{"Ticker":"CVS","EffectiveDate":"2013-12-11","Type":"RatingNeutral","Title":"Credit Suisse maintains CVS to Outperform. Target Price is $75; previously $70.","DailyReturn":0.002206,"FiveDayReturnAfter":-0.017507,"FiveDayReturnBefore":0.018407},{"Ticker":"CVS","EffectiveDate":"2013-12-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.018882,"FiveDayReturnAfter":0.015761,"FiveDayReturnBefore":0.0012},{"Ticker":"CVS","EffectiveDate":"2013-12-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00463,"FiveDayReturnAfter":-0.003141,"FiveDayReturnBefore":0.013079},{"Ticker":"CVS","EffectiveDate":"2013-12-02","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.00463,"FiveDayReturnAfter":-0.003141,"FiveDayReturnBefore":0.013079},{"Ticker":"CVS","EffectiveDate":"2013-11-29","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVS to Overweight. Target Price is $65.","DailyReturn":0.002996,"FiveDayReturnAfter":-0.013421,"FiveDayReturnBefore":0.020276},{"Ticker":"CVS","EffectiveDate":"2013-11-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010332,"FiveDayReturnAfter":-0.000449,"FiveDayReturnBefore":0.020269},{"Ticker":"CVS","EffectiveDate":"2013-11-26","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.010332,"FiveDayReturnAfter":-0.000449,"FiveDayReturnBefore":0.020269},{"Ticker":"CVS","EffectiveDate":"2013-11-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.0015,"FiveDayReturnAfter":-0.000449,"FiveDayReturnBefore":0.016023},{"Ticker":"CVS","EffectiveDate":"2013-11-20","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on CVS to Hold. Target Price is $71.","DailyReturn":0.003067,"FiveDayReturnAfter":0.013251,"FiveDayReturnBefore":0.019508},{"Ticker":"CVS","EffectiveDate":"2013-11-06","Type":"RatingNeutral","Title":"BMO Capital maintains CVS to Outperform. Target Price is $70; previously $66.","DailyReturn":0.010282,"FiveDayReturnAfter":0.011637,"FiveDayReturnBefore":0.010654},{"Ticker":"CVS","EffectiveDate":"2013-11-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.020006,"FiveDayReturnAfter":0.030977,"FiveDayReturnBefore":0.003879},{"Ticker":"CVS","EffectiveDate":"2013-11-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.020006,"FiveDayReturnAfter":0.030977,"FiveDayReturnBefore":0.003879},{"Ticker":"CVS","EffectiveDate":"2013-11-05","Type":"EarningsRevenueBeat","Title":"Before market open, CVS reports 2013 Q3's earning $1.09 per share and revenue $31970MM. This beats analyst's estimated EPS $1.02, beats estimated revenue $31530MM.","DailyReturn":0.020006,"FiveDayReturnAfter":0.030977,"FiveDayReturnBefore":0.003879},{"Ticker":"CVS","EffectiveDate":"2013-10-17","Type":"Dividend","Title":"The Firm pays dividend $0.225","DailyReturn":0.018071,"FiveDayReturnAfter":0.041951,"FiveDayReturnBefore":0.019113},{"Ticker":"CVS","EffectiveDate":"2013-10-07","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CVS to Buy. Target Price is $71.","DailyReturn":-0.002637,"FiveDayReturnAfter":0.046208,"FiveDayReturnBefore":-0.016045},{"Ticker":"CVS","EffectiveDate":"2013-09-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.002417,"FiveDayReturnAfter":-0.006582,"FiveDayReturnBefore":-0.051975},{"Ticker":"CVS","EffectiveDate":"2013-09-13","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on CVS to Market Perform. Target Price is $66.","DailyReturn":0.006554,"FiveDayReturnAfter":0.004862,"FiveDayReturnBefore":0.017802},{"Ticker":"CVS","EffectiveDate":"2013-08-07","Type":"RatingNeutral","Title":"Cantor Fitzgerald downgrades CVS to Hold from Buy. Target Price is $62; previously $65.","DailyReturn":-0.012857,"FiveDayReturnAfter":0.007153,"FiveDayReturnBefore":-0.017709},{"Ticker":"CVS","EffectiveDate":"2013-08-06","Type":"EarningsRevenueBeat","Title":"Before market open, CVS reports 2013 Q2's earning $0.97 per share and revenue $31248MM. This beats analyst's estimated EPS $0.96, beats estimated revenue $31140MM.","DailyReturn":-0.028075,"FiveDayReturnAfter":-0.028645,"FiveDayReturnBefore":-0.000001},{"Ticker":"CVS","EffectiveDate":"2013-08-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.028075,"FiveDayReturnAfter":-0.028645,"FiveDayReturnBefore":-0.000001},{"Ticker":"CVS","EffectiveDate":"2013-08-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.028075,"FiveDayReturnAfter":-0.028645,"FiveDayReturnBefore":-0.000001},{"Ticker":"CVS","EffectiveDate":"2013-08-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.005308,"FiveDayReturnAfter":-0.046589,"FiveDayReturnBefore":0.003867},{"Ticker":"CVS","EffectiveDate":"2013-08-02","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.005308,"FiveDayReturnAfter":-0.046589,"FiveDayReturnBefore":0.003867},{"Ticker":"CVS","EffectiveDate":"2013-07-18","Type":"Dividend","Title":"The Firm pays dividend $0.225","DailyReturn":0.007822,"FiveDayReturnAfter":0.015279,"FiveDayReturnBefore":0.017711},{"Ticker":"CVS","EffectiveDate":"2013-07-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.004489,"FiveDayReturnAfter":0.012227,"FiveDayReturnBefore":0.043493},{"Ticker":"CVS","EffectiveDate":"2013-05-31","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on CVS to Outperform.","DailyReturn":-0.020582,"FiveDayReturnAfter":-0.015428,"FiveDayReturnBefore":0.001533},{"Ticker":"CVS","EffectiveDate":"2013-05-14","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.025961,"FiveDayReturnAfter":0.007317,"FiveDayReturnBefore":0.010474},{"Ticker":"CVS","EffectiveDate":"2013-05-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.008961,"FiveDayReturnAfter":0.024007,"FiveDayReturnBefore":-0.010456},{"Ticker":"CVS","EffectiveDate":"2013-05-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.008961,"FiveDayReturnAfter":0.024007,"FiveDayReturnBefore":-0.010456},{"Ticker":"CVS","EffectiveDate":"2013-05-13","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.008961,"FiveDayReturnAfter":0.024007,"FiveDayReturnBefore":-0.010456},{"Ticker":"CVS","EffectiveDate":"2013-05-13","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.008961,"FiveDayReturnAfter":0.024007,"FiveDayReturnBefore":-0.010456},{"Ticker":"CVS","EffectiveDate":"2013-05-01","Type":"EarningsRevenueBeat","Title":"Before market open, CVS reports 2013 Q1's earning $0.83 per share and revenue $30760MM. This beats analyst's estimated EPS $0.79, beats estimated revenue $30360MM.","DailyReturn":0.009797,"FiveDayReturnAfter":0.006168,"FiveDayReturnBefore":0.002754},{"Ticker":"CVS","EffectiveDate":"2013-05-01","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.009797,"FiveDayReturnAfter":0.006168,"FiveDayReturnBefore":0.002754},{"Ticker":"CVS","EffectiveDate":"2013-04-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.003624,"FiveDayReturnAfter":0.017281,"FiveDayReturnBefore":0.022604},{"Ticker":"CVS","EffectiveDate":"2013-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.003624,"FiveDayReturnAfter":0.017281,"FiveDayReturnBefore":0.022604},{"Ticker":"CVS","EffectiveDate":"2013-04-24","Type":"RatingNeutral","Title":"Citigroup maintains CVS to Buy. Target Price is $70; previously $60.","DailyReturn":-0.007584,"FiveDayReturnAfter":0.002754,"FiveDayReturnBefore":0.010708},{"Ticker":"CVS","EffectiveDate":"2013-04-19","Type":"Dividend","Title":"The Firm pays dividend $0.225","DailyReturn":0.023921,"FiveDayReturnAfter":0.022604,"FiveDayReturnBefore":-0.015529},{"Ticker":"CVS","EffectiveDate":"2013-03-12","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CVS to Neutral from Buy. Target Price is $57.","DailyReturn":-0.01045,"FiveDayReturnAfter":0.021987,"FiveDayReturnBefore":0.014546},{"Ticker":"CVS","EffectiveDate":"2013-02-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.009281,"FiveDayReturnAfter":-0.010691,"FiveDayReturnBefore":0.007374},{"Ticker":"CVS","EffectiveDate":"2013-02-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.009281,"FiveDayReturnAfter":-0.010691,"FiveDayReturnBefore":0.007374},{"Ticker":"CVS","EffectiveDate":"2013-02-06","Type":"EarningsRevenueBeat","Title":"Before market open, CVS reports 2012 Q4's earning $1.14 per share and revenue $31390MM. This beats analyst's estimated EPS $1.1, beats estimated revenue $31130MM.","DailyReturn":-0.009281,"FiveDayReturnAfter":-0.010691,"FiveDayReturnBefore":0.007374},{"Ticker":"CVS","EffectiveDate":"2013-01-22","Type":"Dividend","Title":"The Firm pays dividend $0.225","DailyReturn":0.004336,"FiveDayReturnAfter":-0.01056,"FiveDayReturnBefore":0.015666},{"Ticker":"CVS","EffectiveDate":"2012-12-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000822,"FiveDayReturnAfter":-0.006597,"FiveDayReturnBefore":-0.011642},{"Ticker":"CVS","EffectiveDate":"2012-12-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.000822,"FiveDayReturnAfter":-0.006597,"FiveDayReturnBefore":-0.011642},{"Ticker":"CVS","EffectiveDate":"2012-12-20","Type":"RatingNeutral","Title":"Jefferies maintains CVS to Buy. Target Price is $58; previously $54.","DailyReturn":0.007795,"FiveDayReturnAfter":-0.007205,"FiveDayReturnBefore":0.025135},{"Ticker":"CVS","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"JP Morgan maintains CVS to Overweight. Target Price is $59; previously $57.","DailyReturn":0.015258,"FiveDayReturnAfter":0.012908,"FiveDayReturnBefore":0.037606},{"Ticker":"CVS","EffectiveDate":"2012-12-14","Type":"RatingUpgrade","Title":"Macquarie upgrades CVS to Outperform from Neutral.","DailyReturn":0.015258,"FiveDayReturnAfter":0.012908,"FiveDayReturnBefore":0.037606},{"Ticker":"CVS","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVS to Overweight. Target Price is $55; previously $53.","DailyReturn":0.015258,"FiveDayReturnAfter":0.012908,"FiveDayReturnBefore":0.037606},{"Ticker":"CVS","EffectiveDate":"2012-12-14","Type":"RatingUpgrade","Title":"Macquarie upgrades CVS to Outperform from Neutral. Target Price is $55; previously $50.","DailyReturn":0.015258,"FiveDayReturnAfter":0.012908,"FiveDayReturnBefore":0.037606},{"Ticker":"CVS","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"UBS maintains CVS to Buy. Target Price is $55; previously $53.","DailyReturn":0.015258,"FiveDayReturnAfter":0.012908,"FiveDayReturnBefore":0.037606},{"Ticker":"CVS","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains CVS to Buy. Target Price is $57; previously $55.","DailyReturn":0.015258,"FiveDayReturnAfter":0.012908,"FiveDayReturnBefore":0.037606},{"Ticker":"CVS","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Credit Suisse maintains CVS to Outperform. Target Price is $55; previously $50.","DailyReturn":0.015258,"FiveDayReturnAfter":0.012908,"FiveDayReturnBefore":0.037606},{"Ticker":"CVS","EffectiveDate":"2012-12-13","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.020193,"FiveDayReturnAfter":0.025135,"FiveDayReturnBefore":0.029026},{"Ticker":"CVS","EffectiveDate":"2012-12-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.020193,"FiveDayReturnAfter":0.025135,"FiveDayReturnBefore":0.029026},{"Ticker":"CVS","EffectiveDate":"2012-12-13","Type":"RatingNeutral","Title":"ISI Group maintains CVS to Overweight. Target Price is $57; previously $53.5.","DailyReturn":0.020193,"FiveDayReturnAfter":0.025135,"FiveDayReturnBefore":0.029026},{"Ticker":"CVS","EffectiveDate":"2012-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00854,"FiveDayReturnAfter":0.04997,"FiveDayReturnBefore":0.00707},{"Ticker":"CVS","EffectiveDate":"2012-12-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.00854,"FiveDayReturnAfter":0.04997,"FiveDayReturnBefore":0.00707},{"Ticker":"CVS","EffectiveDate":"2012-11-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011565,"FiveDayReturnAfter":0.014727,"FiveDayReturnBefore":0.024967},{"Ticker":"CVS","EffectiveDate":"2012-11-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011565,"FiveDayReturnAfter":0.014727,"FiveDayReturnBefore":0.024967},{"Ticker":"CVS","EffectiveDate":"2012-11-26","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.011565,"FiveDayReturnAfter":0.014727,"FiveDayReturnBefore":0.024967},{"Ticker":"CVS","EffectiveDate":"2012-11-26","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.011565,"FiveDayReturnAfter":0.014727,"FiveDayReturnBefore":0.024967},{"Ticker":"CVS","EffectiveDate":"2012-11-07","Type":"RatingNeutral","Title":"Jefferies maintains CVS to Buy. Target Price is $54; previously $50.","DailyReturn":-0.004053,"FiveDayReturnAfter":-0.013963,"FiveDayReturnBefore":0.017647},{"Ticker":"CVS","EffectiveDate":"2012-11-07","Type":"RatingNeutral","Title":"Barclays maintains CVS to Overweight. Target Price is $54; previously $50.","DailyReturn":-0.004053,"FiveDayReturnAfter":-0.013963,"FiveDayReturnBefore":0.017647},{"Ticker":"CVS","EffectiveDate":"2012-11-07","Type":"RatingNeutral","Title":"BMO Capital maintains CVS to Outperform. Target Price is $55; previously $53.","DailyReturn":-0.004053,"FiveDayReturnAfter":-0.013963,"FiveDayReturnBefore":0.017647},{"Ticker":"CVS","EffectiveDate":"2012-11-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.005361,"FiveDayReturnAfter":-0.008184,"FiveDayReturnBefore":0.011215},{"Ticker":"CVS","EffectiveDate":"2012-11-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.005361,"FiveDayReturnAfter":-0.008184,"FiveDayReturnBefore":0.011215},{"Ticker":"CVS","EffectiveDate":"2012-11-06","Type":"RatingNeutral","Title":"Jefferies maintains CVS to Buy. Target Price is $54; previously $50.","DailyReturn":0.005361,"FiveDayReturnAfter":-0.008184,"FiveDayReturnBefore":0.011215},{"Ticker":"CVS","EffectiveDate":"2012-11-06","Type":"EarningsRevenueBeat","Title":"After market close, CVS reports 2012 Q3's earning $0.85 per share and revenue $30230MM. This beats analyst's estimated EPS $0.84, beats estimated revenue $30090MM.","DailyReturn":0.005361,"FiveDayReturnAfter":-0.008184,"FiveDayReturnBefore":0.011215},{"Ticker":"CVS","EffectiveDate":"2012-11-06","Type":"RatingNeutral","Title":"ISI Group maintains CVS to Overweight. Target Price is $53.5; previously $54.","DailyReturn":0.005361,"FiveDayReturnAfter":-0.008184,"FiveDayReturnBefore":0.011215},{"Ticker":"CVS","EffectiveDate":"2012-10-18","Type":"Dividend","Title":"The Firm pays dividend $0.163","DailyReturn":0.002216,"FiveDayReturnAfter":-0.011617,"FiveDayReturnBefore":-0.029776},{"Ticker":"CVS","EffectiveDate":"2012-09-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00654,"FiveDayReturnAfter":0.004841,"FiveDayReturnBefore":0.028896},{"Ticker":"CVS","EffectiveDate":"2012-09-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00654,"FiveDayReturnAfter":0.004841,"FiveDayReturnBefore":0.028896},{"Ticker":"CVS","EffectiveDate":"2012-09-19","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.00654,"FiveDayReturnAfter":0.004841,"FiveDayReturnBefore":0.028896},{"Ticker":"CVS","EffectiveDate":"2012-09-19","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.00654,"FiveDayReturnAfter":0.004841,"FiveDayReturnBefore":0.028896},{"Ticker":"CVS","EffectiveDate":"2012-08-14","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on CVS to Buy. Target Price is $55.","DailyReturn":-0.012975,"FiveDayReturnAfter":0.02453,"FiveDayReturnBefore":-0.004466},{"Ticker":"CVS","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"JP Morgan maintains CVS to Overweight. Target Price is $52; previously $51.","DailyReturn":0.032638,"FiveDayReturnAfter":-0.000001,"FiveDayReturnBefore":-0.02529},{"Ticker":"CVS","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Jefferies maintains CVS to Buy. Target Price is $52; previously $50.","DailyReturn":0.032638,"FiveDayReturnAfter":-0.000001,"FiveDayReturnBefore":-0.02529},{"Ticker":"CVS","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Citigroup maintains CVS to Buy. Target Price is $60; previously $52.","DailyReturn":0.032638,"FiveDayReturnAfter":-0.000001,"FiveDayReturnBefore":-0.02529},{"Ticker":"CVS","EffectiveDate":"2012-08-07","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CVS reports 2012 Q2's earning $0.81 per share and revenue $30700MM. This beats analyst's estimated EPS $0.79, misses estimated revenue $30980MM.","DailyReturn":-0.017372,"FiveDayReturnAfter":-0.004466,"FiveDayReturnBefore":-0.009532},{"Ticker":"CVS","EffectiveDate":"2012-08-07","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.017372,"FiveDayReturnAfter":-0.004466,"FiveDayReturnBefore":-0.009532},{"Ticker":"CVS","EffectiveDate":"2012-08-07","Type":"RatingNeutral","Title":"ISI Group maintains CVS to Overweight. Target Price is $51.5; previously $52.","DailyReturn":-0.017372,"FiveDayReturnAfter":-0.004466,"FiveDayReturnBefore":-0.009532},{"Ticker":"CVS","EffectiveDate":"2012-08-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.017372,"FiveDayReturnAfter":-0.004466,"FiveDayReturnBefore":-0.009532},{"Ticker":"CVS","EffectiveDate":"2012-07-19","Type":"Dividend","Title":"The Firm pays dividend $0.163","DailyReturn":-0.062274,"FiveDayReturnAfter":-0.084082,"FiveDayReturnBefore":0.035812},{"Ticker":"CVS","EffectiveDate":"2012-07-17","Type":"RatingNeutral","Title":"JMP Securities assumes CVS to Market Outperform.","DailyReturn":0.007697,"FiveDayReturnAfter":-0.066866,"FiveDayReturnBefore":0.016359},{"Ticker":"CVS","EffectiveDate":"2012-07-12","Type":"RatingNeutral","Title":"ISI Group initiates coverage on CVS to Overweight. Target Price is $53.5.","DailyReturn":0.01322,"FiveDayReturnAfter":0.035812,"FiveDayReturnBefore":-0.019635},{"Ticker":"CVS","EffectiveDate":"2012-05-10","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.016361,"FiveDayReturnAfter":-0.001548,"FiveDayReturnBefore":-0.01514},{"Ticker":"CVS","EffectiveDate":"2012-05-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016361,"FiveDayReturnAfter":-0.001548,"FiveDayReturnBefore":-0.01514},{"Ticker":"CVS","EffectiveDate":"2012-05-10","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.016361,"FiveDayReturnAfter":-0.001548,"FiveDayReturnBefore":-0.01514},{"Ticker":"CVS","EffectiveDate":"2012-05-03","Type":"RatingNeutral","Title":"Jefferies maintains CVS to Buy. Target Price is $52; previously $50.","DailyReturn":0.004791,"FiveDayReturnAfter":-0.01514,"FiveDayReturnBefore":0.047265},{"Ticker":"CVS","EffectiveDate":"2012-05-03","Type":"RatingNeutral","Title":"UBS maintains CVS to Buy. Target Price is $53; previously $49.","DailyReturn":0.004791,"FiveDayReturnAfter":-0.01514,"FiveDayReturnBefore":0.047265},{"Ticker":"CVS","EffectiveDate":"2012-05-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.027063,"FiveDayReturnAfter":0.012447,"FiveDayReturnBefore":0.029276},{"Ticker":"CVS","EffectiveDate":"2012-05-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.027063,"FiveDayReturnAfter":0.012447,"FiveDayReturnBefore":0.029276},{"Ticker":"CVS","EffectiveDate":"2012-05-01","Type":"EarningsRelease","Title":"Before market open, CVS reports 2012 Q1's earning $0.59 per share and revenue $30798MM..","DailyReturn":0.002017,"FiveDayReturnAfter":0.014241,"FiveDayReturnBefore":0.031184},{"Ticker":"CVS","EffectiveDate":"2012-04-19","Type":"Dividend","Title":"The Firm pays dividend $0.163","DailyReturn":-0.002463,"FiveDayReturnAfter":0.008323,"FiveDayReturnBefore":-0.003434},{"Ticker":"CVS","EffectiveDate":"2012-03-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006951,"FiveDayReturnAfter":-0.006523,"FiveDayReturnBefore":-0.006927},{"Ticker":"CVS","EffectiveDate":"2012-03-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.006951,"FiveDayReturnAfter":-0.006523,"FiveDayReturnBefore":-0.006927},{"Ticker":"CVS","EffectiveDate":"2012-03-13","Type":"RatingNeutral","Title":"BMO Capital downgrades CVS to Market Perform from Outperform. Target Price is $47.","DailyReturn":-0.002866,"FiveDayReturnAfter":-0.005083,"FiveDayReturnBefore":0.004196},{"Ticker":"CVS","EffectiveDate":"2012-03-07","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVS to Overweight. Target Price is $52; previously $48.","DailyReturn":-0.001786,"FiveDayReturnAfter":0.009775,"FiveDayReturnBefore":-0.002676},{"Ticker":"CVS","EffectiveDate":"2012-03-01","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.002439,"FiveDayReturnAfter":-0.008686,"FiveDayReturnBefore":0.031764},{"Ticker":"CVS","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"Goldman Sachs maintains CVS to Buy. Target Price is $48; previously $46.","DailyReturn":-0.013082,"FiveDayReturnAfter":-0.000919,"FiveDayReturnBefore":0.021341},{"Ticker":"CVS","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"UBS maintains CVS to Buy. Target Price is $49; previously $48.","DailyReturn":-0.013082,"FiveDayReturnAfter":-0.000919,"FiveDayReturnBefore":0.021341},{"Ticker":"CVS","EffectiveDate":"2012-02-08","Type":"RatingNeutral","Title":"Citigroup maintains CVS to Buy. Target Price is $51; previously $45.","DailyReturn":0.011374,"FiveDayReturnAfter":0.006939,"FiveDayReturnBefore":0.031359},{"Ticker":"CVS","EffectiveDate":"2012-02-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.011374,"FiveDayReturnAfter":0.006939,"FiveDayReturnBefore":0.031359},{"Ticker":"CVS","EffectiveDate":"2012-02-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.011374,"FiveDayReturnAfter":0.006939,"FiveDayReturnBefore":0.031359}];